BioPacific Conference 2014 Agenda

Theme: Innovation through collaboration and partnership

Saturday, June 14, 2014, Crown Plaza Hotel, Foster City, CA, USA

8:00 am Registration and Vendor Exhibition
9:00 am Welcome Remarks
Alan Hao, PhD, CABS President-elect & 2014 BioPacific Conference Organizing Committee Chair
9:05 am State of the Society
Zhonghua Pei, PhD, CABS President
  Session I: Success Stories and Case Studies of Innovative New Medicines
Session chairpersons: Charlene Liao, Jianlong Lou & Yang Tian
9:15 am Genentech Portfolio and Collaborations
Ann Lee-Karlon, PhD, SVP of Genentech
9:45 am “ISPY-2” Clinical Trials
Hope S. Rugo, MD, Professor of Medicine at UCSF
10:15 am The Story of Sofosbuvir and the Race to Cure HCV
William Lee, PhD, SVP of Gilead
10:45 am Break, Vendor Exhibition & Networking
11:05 am CABS K. Fong Award in Life Sciences
Session chairperson: Zhonghua Pei
Award Winners: Drs. Ge Li & Hing L. Sham
11:10 am Award Winner Speech
  Session II: Drug Discovery Research & Development through Collaboration
Session chairpersons: Jiangwen Majeti & Jianlong Lou
11:30 pm Lessons from Silicon Valley
Stephanie Marrus, MBA, Director of Entrepreneurship Center at UCSF
12:00 am Convergence in Healthcare
Lee Babiss, PhD, CSO & EVP PPD Discovery Innovation, CEO X-Rx Discovery Inc
12:30 pm Lunch
  Session III: Diagnostics, Medical Devices and Life Science Investment
Session chairpersons: Janet Xiao & Wentao Zhang
1:20 pm Next Generation Tools for Studying the Genomics in Cancer
Gary Schroth, PhD, Distinguished Scientist of Illumina
1:45 pm Biomedical Device Design through Computational Modeling, Bench Testing, and Preclinical Models
Chad Abunassar, Staff R&D Engineer, Abbott Vascular
2:10 pm Bridging China-US: Life Science Investments and Strategic Partnerships
Frank Yu, Co-founder and CEO of Ally Bridge & Themes Investment
2:35 pm Patent Owners: Don’t Get Caught in the Tsunami: AIA Post-Grant Proceedings
Thomas L. Irving, Partner, Finnegan
2:55 pm Gold Sponsor Presentations
Kelly Tan, Contact Singapore, Area Director, North America
Chunlin Chen, CEO, Shanghai Medicilon
Jeffrey Hung, VP of Service Marketing, GenScript
3:15 pm Break: Vendor Exhibition & Networking
  Session IV: Drug Research & Development Trend in China
Session chairpersons: Connie Sun & Zhenhai Shen
3:45 pm Pharmaceutical R&D in China: Where Shall We Go from Here?
Dayao Zhao, PhD, Vice President, J & J China R&D and Scientific Affairs
4:10 pm The New Trends in Global Clinical Development & the Status in China
Joan Shen, PhD, VP of Jiangsu Hengrui Pharma
4:35 pm Gold Sponsor Presentations
Connie Sun, SVP of Business and Corporate Development, Pharmaron
Caroline Lee, Director, Drug Transporter Sciences, QPS
Charles Huang, VP of Global BD, Sundia
Craig Coburn, VP, Medicinal Chemistry, International Discovery Unit, WuXi AppTec
5:05 pm Hangzhou HEDA: Recruiting Talents and Projects
Chenpeng Yao, President and CEO, HEDA Asset Management
5:30 pm Dinner
6:30 pm Session V: Panel Discussion: Returnees’ Work Experience in China
Chunlin Chen, PhD, CEO, Medicilon
Wayne Li, PhD, GM, Kunming Biomed International & Harmonia Biotechnology, Investing Director, Morningside Technologiesn
Henry Lu, PhD, VP & Head of Biology, Wuxi Apptec
Qiang Lu, PhD, CSO, Yangtze River Pharma
Joan Shen, MD, PhD, CMO & VP, Hengrui Medicine
Yingfei Wei, PhD, CEO of Elixirin, former CSO, 3S Bio Inc
Dayao Zhao, MD PhD, VP, China R&D and Scientific Affairs
8:30 pm Conference Adjourned